Viewing Study NCT04995159

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 2:22 PM
Ignite Modification Date: 2026-03-05 @ 8:40 AM
Study NCT ID: NCT04995159
Status: NOT_YET_RECRUITING
Last Update Posted: 2021-08-06
First Post: 2021-07-29
Is Gene Therapy: True
Has Adverse Events: False
Brief Title: Optimized Antiplatelet Therapy in Patients With CHD After Implantation of NeoVas™ BRS System
Sponsor: Lepu Medical Technology (Beijing) Co., Ltd.
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Coronary Heart Disease View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Bioabsorbable Coronary Artery Rapamycin-eluting Stent System View
None Optimized Antiplatelet Therapy View
None Coronary Heart Disease View
None Randomized Controlled Trial View